Hypercalcemia Clinical Trials
Conditions / Hypercalcemia
Delta Trials indexes 27 clinical trials for Hypercalcemia in its publicly accessible dataset. Of these, 4 enrolling participants at this time and 16 trials have reached completion. This research takes place spanning 65 research sites around the world. An additional 7 trials are in preparatory or other active non-recruiting stages. Since 2020, 2 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
27
Total Trials
4
Recruiting
16
Completed
7
Other Active
2
Terminated since 2020
65
Study Locations
Browse by location (65 total)
- Bethesda, United States 2 trialsAll trials in Bethesda, United States
- Calgary, Canada 2 trialsAll trials in Calgary, Canada
- Oakville, Canada 1 trialAll trials in Oakville, Canada
- Riyadh, Saudi Arabia 1 trialAll trials in Riyadh, Saudi Arabia
- Milan, Italy 1 trialAll trials in Milan, Italy
- Budapest, Hungary 1 trialAll trials in Budapest, Hungary
- Coimbra, Portugal 1 trialAll trials in Coimbra, Portugal
- London, Canada 1 trialAll trials in London, Canada
- Callao, Peru 1 trialAll trials in Callao, Peru
- Sendai, Japan 1 trialAll trials in Sendai, Japan
- Lake Forest, United States 1 trialAll trials in Lake Forest, United States
- Herlev, Denmark 1 trialAll trials in Herlev, Denmark
- Melbourne, United States 1 trialAll trials in Melbourne, United States
- Szeged, Hungary 1 trialAll trials in Szeged, Hungary
- Ann Arbor, United States 1 trialAll trials in Ann Arbor, United States
- Randwick, Australia 1 trialAll trials in Randwick, Australia
- Toledo, United States 1 trialAll trials in Toledo, United States
- Detroit, United States 1 trialAll trials in Detroit, United States
- Washington D.c, United States 1 trialAll trials in Washington D.c, United States
- Geelong, Australia 1 trialAll trials in Geelong, Australia